Cialis has managed overtake Viagra in some national markets

The pharmaceutical giant Eli Lilly has issued a statement regarding its erectile dysfunction medication Cialis and are extremely bullish about its future prospects and the possibility of gaining a greater market share of the world wide impotence drugs market. In the first three financial quarters of 2008 Cialis has already generated over $1 billion in sales for Eli Lilly and it looks like this year will be a record year. The Cialis drug is now available in over 100 different countries worldwide and has managed to gain the largest market share in twenty of them. 

The fact that Cialis has managed overtake Viagra in some national markets shows how popular the drug is and gives credibility to the ambitions of the Cialis marketing team who say that they want to make Cialis the world’s best selling erectile dysfunction medication. One of the reasons why Cialis is selling so well is that in America a new version of the drug has been launched called Cialis Once A Day which has proved to be very popular with certain groups of men.

The future for Cialis is also bright because clinical trials have shown that it is effective in treating Pulmonary Arterial Hypertension as well as Benign Prostatic Hyperplasia and applications have been filed by Eli Lilly to be allowed to sell Cialis in a different packaging and under different names to treat these two conditions.

The great advantage that Cialis has over its rivals Viagra and Levitra is that it works for much longer than the other two. While Viagra and Levitra have a four hour time window time for effectiveness, Cialis can work for as long as 36 hours with one dose.

Cialis is the best selling erectile dysfunction medication in France and has been nicknamed ‘Le Weekend Pill’ there.